Cargando…
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infection
A soluble ACE2 protein bioengineered for long duration of action and high affinity to SARS-CoV-2 was administered either intranasally (IN) or intraperitoneally (IP) to SARS-CoV-2–inoculated k18hACE2 mice. This decoy protein (ACE2 618-DDC-ABD) was given either IN or IP, pre- and post-inoculation, or...
Autores principales: | Hassler, Luise, Wysocki, Jan, Ahrendsen, Jared T, Ye, Minghao, Gelarden, Ian, Nicolaescu, Vlad, Tomatsidou, Anastasia, Gula, Haley, Cianfarini, Cosimo, Forster, Peter, Khurram, Nigar, Singer, Benjamin D, Randall, Glenn, Missiakas, Dominique, Henkin, Jack, Batlle, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098141/ https://www.ncbi.nlm.nih.gov/pubmed/37041017 http://dx.doi.org/10.26508/lsa.202301969 |
Ejemplares similares
-
Spherical nucleic acids as an infectious disease vaccine platform
por: Teplensky, Michelle H., et al.
Publicado: (2022) -
ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010) -
Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Batlle, Daniel, et al.
Publicado: (2022) -
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
por: El-Shennawy, Lamiaa, et al.
Publicado: (2022) -
Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
por: Wysocki, Jan, et al.
Publicado: (2013)